ReviewLaryngoscope investigative otolaryngology2025
Blood Labyrinth Barrier Waste Clearance as Assessed by GBCAs on MRI: A Scoping Review.
Review in Laryngoscope investigative otolaryngology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Blood Labyrinth Barrier Waste Clearance as Assessed by GBCAs on MRI: A Scoping Review.Laryngoscope investigative otolaryngology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Objective: The discovery of the glymphatic system in the brain and eye has raised the hypothesis of a similar system in the inner ear. Dysfunctional lymph fluid dynamics may contribute to inner ear conditions such as Meniere's Disease (MD) and endolymphatic hydrops (EH). This scoping review evaluates inner ear waste clearance mechanisms by tracking gadolinium-based contrast agent (GBCA) signal over time using magnetic resonance imaging. Data Sources: PubMed, Embase, Cochrane, Web of Science, and Scopus. Review Methods: A systematic search identified studies reporting inner ear GBCA signal > 4 h after intravenous (IV) administration. Data on study design, cohort characteristics, and time points were extracted. Results: Fifteen studies (three animal; 12 human) met inclusion criteria. Three studies had a goal of studying clearance. Animal studies demonstrated a decrease in GBCA signal following a 4-h peak. Of the human studies, three analyzed healthy controls, four studied EH without MD, three focused on MD, and two focused on neurological disorders but provided insight into inner ear enhancement. In healthy and MD ears, the internal auditory canal was enhanced before other inner ear structures. In EH, a reduced superior petrosal sinus area was noted, and delayed excretion rates were observed in MD patients 24 h post-IV administration. A positive association between endolymph and perilymph signal was identified in EH patients after 24 h. Conclusions: Most studies were not designed to assess clearance mechanisms. Future in vivo and histopathological studies are needed to clarify the potential presence of glymphatic system involvement in the inner ear.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.